Rare
lephants
Knowledge
Value Investing
What is Value Investing?
What Is a Moat?
Intangible Assets
Cost Advantage
Pricing Power
Network Effect
Switching Costs
Efficient Scale
Intrinsic Value
Margin of Safety
Circle of Competence
Mr. Market
ROIC
Financial Statements
Income Statement
High Gross Margins
R&D Spending
Sales & Marketing
Net Margin
Balance Sheet
Long-Term Debt
Float
Receivables/Payables
Derivatives
Cash Flow Statement
Free Cash Flow
Shareholder Returns
Cap Ex
Stock-Based Compensation
Berkshire Hathaway Lessons
The Four Criteria — 1977
Rare Fast-Moving Elephants — 1987
Mr. Market — 1987
Wonderful Companies at Fair Prices — 1989
Risk Isn’t Volatility — 1993
Circle of Competence — 1996
Swimming Naked — 2001
“Price Is What You Pay...” — 2008
Famous Value Investors
Benjamin Graham
Warren Buffett
Charlie Munger
Phil Fisher
Peter Lynch
Howard Marks
Screener
Toggle theme
NewAmsterdam Pharma Company N.V.
NAMS
·
Healthcare, Drug Manufacturers - General, Netherlands
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Profit History
Profit Flow
Profit Margins
Returns on Capital
Profitability
›
Profit Flow
Profit Flow
FY2025
FY2024
FY2023
FY2022
